Nathaniel Erdmann
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 2
- Viral gastroenteritis research and epidemiology 2
-
- Long-Term Effects of COVID-19 3
- Co-authors
- Ashlesha Deshpande (2 shared papers)Michael S. Piepenbrink (3 shared papers)Jennifer Woo (2 shared papers)Paul A. Goepfert (5 shared papers)Luis Martínez‐Sobrido (3 shared papers)Amit Gaggar (3 shared papers)Jun‐Gyu Park (2 shared papers)Michael J. Patton (2 shared papers)
- Journals
- JCI Insight (2 papers)PLoS Pathogens (1 paper)Frontiers in Endocrinology (1 paper)Critical Care (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- United StatesPolandEgypt
In The Last Decade
Nathaniel Erdmann
13 papers receiving 193 citations
Peers
Comparison fields: 5 of 61
- Applied Microbiology and Biotechnology 19
- Infectious Diseases 116
- Critical Care and Intensive Care Medicine 15
- Transplantation 5
- Nephrology 12
Countries citing papers authored by Nathaniel Erdmann
This map shows the geographic impact of Nathaniel Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Erdmann more than expected).
Fields of papers citing papers by Nathaniel Erdmann
This network shows the impact of papers produced by Nathaniel Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Erdmann. The network helps show where Nathaniel Erdmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathaniel Erdmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 50 | |
| 2 | 2021 | 50 | |
| 3 | 2022 | 18 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 16 | |
| 6 | 2018 | 10 | |
| 7 | 2020 | 8 | |
| 8 | 2024 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2018 | 1 | |
| 14 | 2024 | 0 |
About Nathaniel Erdmann
Nathaniel Erdmann is a scholar working on Infectious Diseases, Neurology, Epidemiology, Emergency Medicine and Critical Care and Intensive Care Medicine, having authored 14 papers that have together received 194 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Long-Term Effects of COVID-19 (3 papers), HIV Research and Treatment (2 papers), Animal Virus Infections Studies (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), COVID-19 Clinical Research Studies (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Infectious Diseases (116 citations), Critical Care and Intensive Care Medicine (15 citations), Transplantation (5 citations) and Nephrology (12 citations). Nathaniel Erdmann has collaborated with scholars based in United States, Poland and Egypt. Frequent co-authors include Ashlesha Deshpande, Michael S. Piepenbrink, Jennifer Woo, Paul A. Goepfert, Luis Martínez‐Sobrido, Amit Gaggar, Jun‐Gyu Park, Michael J. Patton, James J. Kobie and Sanghita Sarkar. Their work appears in journals such as JCI Insight, PLoS Pathogens, Frontiers in Endocrinology, Critical Care and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.